| Bone Marrow Transplant | 7.19.07 and 7.19.10 |
| Cardiac | 7.02.11 |
| Cochlear Implant | 7.36.2 and 7.36.16
|
| Communication Disorder Center Type C | 7.35.88 |
| Craniofacial | 7.03.10 |
| Cystic Fibrosis and Pulmonary Diseases | 7.11.28 |
| Endocrine | 7.09.12B |
| Epilepsy | 7.20.20 |
| Gastrointestinal | 7.23.02 |
| Heart Transplant | 7.27.04 |
| Hematology/Oncology | 7.16.09 |
| High Risk Infant Follow-up (Regional) | 7.37.18 |
| Infectious Disease and Immunologic Disorders | 7.26.02 |
| Liver Transplant | 7.28.03 |
| Metabolic | 7.09.12A |
| Neonatal Intensive Care Unit (Regional) | 7.12.18 |
| Neuromuscular | 7.20.27 |
| Pediatric Intensive Care Unit | 7.25.04 |
| Renal Dialysis and Transplant | 7.10.07 |
| Rheumatology Disease | 7.20C.2 |
| Selective Posterior Rhizotomy | 7.30.03 |
| Sickle Cell Disease | 7.17.09 |
| Specified Inherited Neurological Diseases | 7.24.05 |
